These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7524749)

  • 1. Granzyme B-expressing peripheral T-cell lymphomas: neoplastic equivalents of activated cytotoxic T cells with preference for mucosa-associated lymphoid tissue localization.
    de Bruin PC; Kummer JA; van der Valk P; van Heerde P; Kluin PM; Willemze R; Ossenkoppele GJ; Radaszkiewicz T; Meijer CJ
    Blood; 1994 Dec; 84(11):3785-91. PubMed ID: 7524749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
    Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
    Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules.
    Foss HD; Anagnostopoulos I; Araujo I; Assaf C; Demel G; Kummer JA; Hummel M; Stein H
    Blood; 1996 Nov; 88(10):4005-11. PubMed ID: 8916967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
    Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P
    J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients.
    Kagami Y; Suzuki R; Taji H; Yatabe Y; Takeuchi T; Maeda S; Kondo E; Kojima M; Motoori T; Mizoguchi Y; Okamoto M; Ohnishi K; Yamabe H; Seto M; Ogura M; Koshikawa T; Takahashi T; Kurita S; Morishima Y; Suchi T; Nakamura S
    Am J Surg Pathol; 1999 Oct; 23(10):1184-200. PubMed ID: 10524519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perforin and granzyme expression in cytotoxic T-cell lymphomas.
    Yamashita Y; Yatabe Y; Tsuzuki T; Nakayama A; Hasegawa Y; Kojima H; Nagasawa T; Mori N
    Mod Pathol; 1998 Apr; 11(4):313-23. PubMed ID: 9578080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease.
    Oudejans JJ; Kummer JA; Jiwa M; van der Valk P; Ossenkoppele GJ; Kluin PM; Kluin-Nelemans JC; Meijer CJ
    Am J Pathol; 1996 Jan; 148(1):233-40. PubMed ID: 8546210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enteropathy-associated T-cell lymphomas have a cytotoxic T-cell phenotype.
    de Bruin PC; Connolly CE; Oudejans JJ; Kummer JA; Jansen W; McCarthy CF; Meijer CJ
    Histopathology; 1997 Oct; 31(4):313-7. PubMed ID: 9363445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical and genetic analysis of Chinese nasal natural killer/T-cell lymphomas.
    Li T; Zhang B; Ye Y; Yin H
    Hum Pathol; 2006 Jan; 37(1):54-60. PubMed ID: 16360416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
    Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
    Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype.
    Kummer JA; Vermeer MH; Dukers D; Meijer CJ; Willemze R
    J Invest Dermatol; 1997 Nov; 109(5):636-40. PubMed ID: 9347791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?
    Bladergroen BA; Meijer CJ; ten Berge RL; Hack CE; Muris JJ; Dukers DF; Chott A; Kazama Y; Oudejans JJ; van Berkum O; Kummer JA
    Blood; 2002 Jan; 99(1):232-7. PubMed ID: 11756176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nodal T/NK-cell lymphoma of nasal type: a clinicopathological study of six cases.
    Takahashi E; Asano N; Li C; Tanaka T; Shimada K; Shimada S; Yoshino T; Kojima M; Hara K; Eimoto T; Nakamura S
    Histopathology; 2008 Apr; 52(5):585-96. PubMed ID: 18370955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status.
    Ko YH; Cho EY; Kim JE; Lee SS; Huh JR; Chang HK; Yang WI; Kim CW; Kim SW; Ree HJ
    Histopathology; 2004 May; 44(5):480-9. PubMed ID: 15139996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: high prevalence of p53 overexpression.
    Quintanilla-Martinez L; Franklin JL; Guerrero I; Krenacs L; Naresh KN; Rama-Rao C; Bhatia K; Raffeld M; Magrath IT
    Hum Pathol; 1999 Jul; 30(7):849-55. PubMed ID: 10414505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, immunohistochemical and phenotypic features of aggressive nodal cytotoxic lymphomas, including alpha/beta, gamma/delta T-cell and natural killer cell types.
    Ohshima K; Suzumiya J; Sugihara M; Kanda M; Shimazaki K; Kawasaki C; Haraoka S; Kikuchi M
    Virchows Arch; 1999 Aug; 435(2):92-100. PubMed ID: 10599306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal T cell lymphoma: predominant cytotoxic phenotypes, including alpha/beta, gamma/delta T cell and natural killer cells.
    Katoh A; Ohshima K; Kanda M; Haraoka S; Sugihara M; Suzumiya J; Kawasaki C; Shimazaki K; Ikeda S; Kikuchi M
    Leuk Lymphoma; 2000 Sep; 39(1-2):97-111. PubMed ID: 10975388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percentage of activated cytotoxic T-lymphocytes in anaplastic large cell lymphoma and Hodgkin's disease: an independent biological prognostic marker.
    ten Berge RL; Oudejans JJ; Dukers DF; Meijer JW; Ossenkoppele GJ; Meijer CJ
    Leukemia; 2001 Mar; 15(3):458-64. PubMed ID: 11237071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granzyme B immunoreactivity in T/natural killer cell lymphomas.
    Cho MS; Lee MK; Yang WI; Yoon JH
    Yonsei Med J; 1997 Oct; 38(5):285-93. PubMed ID: 9409191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of PIK3CA and FOXP1 in gastric and intestinal non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue type.
    Zhai L; Zhao Y; Ye S; Huang H; Tian Y; Wu Q; Lin H; Lin T
    Tumour Biol; 2011 Oct; 32(5):913-20. PubMed ID: 21660567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.